Abbvie Inc. vs Humana Inc.
ABBV vs HUM — side-by-side comparison from reported financials. ABBV leads 5, HUM leads 7 of 12 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Humana Inc.
HUM · Healthcare
$438.49+13.27%Mixed
| Metric | ABBV | HUM |
|---|---|---|
| Price | $276.43 | $438.49 |
| Market cap | $488B | $52.6B |
| Revenue (TTM) | $64.4B | $146B |
| Revenue growth | +1.8% | +11.8% |
| Net margin | 9.8% | 0.9% |
| Free cash flow | $18.2B | $1.95B |
| Net cash (debt) | ($56.2B) | $7.53B |
| 1-year price return | +19.8% | +50.9% |
| P/E | 77.4 | 40.5 |
| P/E vs own history (cheap-side %) | 23% | 0% |
| Dividend yield | 2.45% | 0.83% |
| Return on equity | 96% | 7% |
| Altman Z-score | 2.33 | 2.34 |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 57,000 | 67,060 |
Full résumé-style profiles: ABBV CV · HUM CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.